Table 3:
Patient, tumor, and treatment characteristics stratified by post-treatment PET/CT results.
| Positive PET | Negative PET | p-value | |
|---|---|---|---|
| Sex | |||
| Male | 11 | 48 | 1.000 |
| Female | 0 | 3 | |
| Race | |||
| White | 11 | 48 | 1.000 |
| Non-white | 0 | 4 | |
| CTV Margin | 0.152 | ||
| No | 1 | 17 | |
| Yes | 10 | 34 | |
| Smoking History | 0.748 | ||
| No | 4 | 22 | |
| Yes | 7 | 29 | |
| >10 pack year history | 0.726 | ||
| No | 7 | 35 | |
| Yes | 4 | 15 | |
| Primary Site | 0.200 | ||
| Tonsil | 7 | 21 | |
| BOT | 4 | 30 | |
| T stage | 0.735 | ||
| T1-T2 | 8 | 33 | |
| T3-T4 | 3 | 18 | |
| N Stage | 0.674 | ||
| N0 | 1 | 9 | |
| N1-2 | 10 | 42 | |
| Concurrent chemotherapy | 0.363 | ||
| No | 3 | 7 | |
| Yes | 8 | 44 | |
| Loco-regional Failure | 0.326 | ||
| No | 10 | 51 | |
| Yes | 1 | 1 |